XML 34 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Loss Per Common Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following common stock equivalents were excluded from the calculation of diluted net loss per share applicable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
 As of March 31, 2026:
 20262025
Anti-dilutive common stock equivalents:
October 2024 Common Warrants2,398,4142,398,414 
March 2025 Common Warrants8,316,8828,316,882 
July 2025 Common Warrants3,076,921— 
January 2026 Series A Common Warrants26,926,675— 
January 2026 Series B Common Warrants26,926,675— 
January 2026 Series C Common Warrants26,926,675— 
Stock options outstanding2,327,4651,595,263
Unvested RSAs— 40,137
Unvested RSUs148,350330,500 
Total anti-dilutive common stock equivalents97,048,05712,681,196